No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study
Open accessAbstract
Phytoestrogens, plant food components with estrogen-like biological properties, are hypothesized to contribute to the 5-fold lower breast cancer incidence in Asian compared with Western countries (1). Isoflavones comprise the phytoestrogens most abundant in soy, the traditional staple food in Asia, and a recent meta-analysis concluded that there was a slight reduction in premenopausal breast cancer risk with higher soy consumption (1). Because consumption of soy and isoflavones is typically low in Western countries, lignans and their derived metabolites, the enterolignans, might be more relevant for breast cancer prevention in these populations (2). Further large prospective studies of phytoestrogens in breast cancer are needed in Western populations to test this hypothesis. We thus examined the association between the usual dietary intake of phytoestrogens and the risk of premenopausal invasive breast cancer in a large French cohort.E3N (Etude Epidémiologique auprès de femmes de la Mutuelle Générale de l'Education Nationale) is a large ongoing prospective cohort consisting of 98,995 French women born between 1925 and 1950, subscribing to the health insurance plan for public education system employees, and who voluntarily enrolled in 1990-1991 (3). After a baseline questionnaire, follow-up questionnaires have been sent biennially to ascertain occurrence of diseases and to update menopausal status and exposure factors. Usual diet over the previous year was assessed using a…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Of 11 prospective cohort studies reporting on risk of primary breast cancer, one (9%) showed soy isoflavone intake was associated with overall reduced risk, while the remaining studies showed no associations.
“Of 11 studies reporting on risk of primary breast cancer, one (9%) showed that soy isoflavone intake was associated with overall reduced risk of breast cancer [116], while the remaining studies showed no associations [99,104,105,107-109,111,113-115,117].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [113]
Cites
Verkasalo, P. K., Appleby, P. N., Allen, N. E., Davey, G., Adlercreutz, H., & Key, T. J. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001424 · Cited by 101 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology of soy exposures and breast cancer risk
Wu, A. H., Yu, M. C., Tseng, C.-C., & Pike, M. C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604145 · Cited by 418 · see citing works
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188 · see citing works
Zhao, T.-T., Jin, F., Li, J.-G., Xu, Y.-Y., Dong, H.-T., Liu, Q., Xing, P., Zhu, G.-L., Xu, H., & Miao, Z.-F. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.006 · Cited by 105 · see citing works
- Authors
- Touillaud, M. S., Thiébaut, A. C. M., Niravong, M., Boutron-Ruault, M.-C., & Clavel-Chapelon, F.
- Affiliations
- Inserm (FR)
- INSERM (Institut National de la Santé et de la Recherche Médicale), ERI-20, Institut Gustave-Roussy, Villejuif, France and 2National Cancer Institute, Division of Cancer Epidemiology and Genetics, Nutritional Epidemiology Branch, NIH, Department of Health and Human Services, Bethesda, Maryland
- ORCID
- Touillaud, Marina S.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2006-12-01
- Volume
- 15
- Issue
- 12
- Pages
- 2574-2576
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2159975668
- Cited by
- 46
- References
- 1
- Citations by year
- 2025: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2014: 1 · 2013: 5 · 2012: 5
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
- inserm.hal.science
- Licence
- other-oa
- Locations
- Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
- Keywords
- phytoestrogens, premenopausal breast cancer, isoflavones, lignans, enterolignans, soy consumption, dietary intake, breast cancer risk, French women, E3N cohort, genistein, daidzein, coumestrol, pinoresinol, secoisolariciresinol, matairesinol, enterodiol
- MeSH terms
- Breast Neoplasms, Diet, Female, France, Humans, Middle Aged, Prospective Studies, Case-Control Studies, Premenopause, Phytoestrogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review